Literature DB >> 11114403

Detailed distribution of Neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study.

X Langlois1, C Wintmolders, P te Riele , J E Leysen, M Jurzak.   

Abstract

The neurokinin 3 (NK3) receptor is predominantly expressed in the central nervous system (CNS). Species differences in neurokinin 3 (NK3) receptor pharmacology have led to the preferential use of guinea pigs and gerbils in the characterization of non-peptide NK3 antagonists. Little is known about the central localization of NK3 receptors in the CNS of these species. To study this, [(3)H]senktide and [(3)H]SR 142801 were used in autoradiography experiments to visualize the NK3 receptors in the guinea pig and gerbil brain and compared to with the distribution of [(3)H]senktide binding sites in the rat brain. In the three species, the NK3 receptor was similarly distributed within the cerebral cortex, the zona incerta, the medial habenula, the amygdaloid complex, the superior colliculus and the interpeduncular nucleus. Outside of these structures, our study has revealed that each species displayed a specific distribution pattern of central NK3 receptors. The rat was the only species where NK3 receptors could be visualized in the striatum, the supraoptic nucleus and the paraventricular nucleus of the hypothalamus. The guinea pig differed mainly from the two other species by the absence of detectable binding sites in the substantia nigra pars compacta and the ventral tegmental area. A specific localization of NK3 receptors in the anterodorsal and anteroventral thalamic nuclei characterized the gerbil. This last species is also unique by in the higher level of NK3 receptors in the dorsal and median raphe nuclei. All these differences suggest that the NK3 receptor mediates different functions in different species.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11114403     DOI: 10.1016/s0028-3908(00)00149-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.

Authors:  P Malherbe; F Knoflach; M C Hernandez; T Hoffmann; P Schnider; R H Porter; J G Wettstein; T M Ballard; W Spooren; L Steward
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.

Authors:  Kathleen Deschamps; Réjean Couture
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

3.  Evidence for mediation of nociception by injection of the NK-3 receptor agonist, senktide, into the dorsal periaqueductal gray of rats.

Authors:  Gabriel S Bassi; Ana C Broiz; Margarete Z Gomes; Marcus L Brandão
Journal:  Psychopharmacology (Berl)       Date:  2008-12-18       Impact factor: 4.530

4.  Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.

Authors:  Helaine De Brito Gariepy; Réjean Couture
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

5.  Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study.

Authors:  Andrée Lessard; Maria M Campos; Witold Neugebauer; Réjean Couture
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

6.  Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity.

Authors:  Chinwe A Nwaneshiudu; Ellen M Unterwald
Journal:  Neuropharmacology       Date:  2009-06-03       Impact factor: 5.250

7.  Substance P depolarizes striatal projection neurons and facilitates their glutamatergic inputs.

Authors:  Craig Blomeley; Enrico Bracci
Journal:  J Physiol       Date:  2008-02-28       Impact factor: 5.182

8.  Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling.

Authors:  Dang Q Dao; Erika E Perez; Yanfen Teng; John A Dani; Mariella De Biasi
Journal:  J Neurosci       Date:  2014-03-19       Impact factor: 6.167

9.  Crystal structure of the human NK1 tachykinin receptor.

Authors:  Jie Yin; Karen Chapman; Lindsay D Clark; Zhenhua Shao; Dominika Borek; Qingping Xu; Junmei Wang; Daniel M Rosenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-11       Impact factor: 12.779

10.  Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits.

Authors:  Judith A Siuciak; Sheryl A McCarthy; A N Martin; D S Chapin; J Stock; D M Nadeau; S Kantesaria; D Bryce-Pritt; S McLean
Journal:  Psychopharmacology (Berl)       Date:  2007-06-10       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.